Your browser doesn't support javascript.
loading
Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients
Forlenza, Orestes Vicente; Stoppe Júnior, Alberto; Hirata, Edson Shiguemi; Ferreira, Rita Cecília Reis.
Afiliación
  • Forlenza, Orestes Vicente; Universidade de São Paulo.
  • Stoppe Júnior, Alberto; Universidade de São Paulo.
  • Hirata, Edson Shiguemi; Universidade de São Paulo.
  • Ferreira, Rita Cecília Reis; Universidade de São Paulo.
São Paulo med. j ; São Paulo med. j;118(4): 99-104, July 2000.
Article en En | LILACS | ID: lil-264470
Biblioteca responsable: BR1.1
RESUMO
CONTEXT Most double-blind studies of efficacy and tolerability of sertraline as compared to tricyclics in the treatment of late-life major depression have used amitriptyline as a standard, leading to the inevitable conclusion that the former drug is better tolerated than the latter, with both being equally efficacious.

OBJECTIVE:

To compare the antidepressant efficacy and tolerability of sertraline (50 mg/day) and imipramine (150 mg/day) in the first 6 weeks of the treatment of major depression in the elderly.

DESIGN:

A randomized double-blind parallel study with 6 weeks of follow-up.

SETTING:

The psychogeriatric clinic at the Institute of Psychiatry, Hospital das Clínicas, Faculty of Medicine of the University of São Paulo.

PARTICIPANTS:

55 severe and moderately depressed non-demented outpatients aged 60 years or more. INTERVENTION Patients were assigned to sertraline 50 mg/day or imipramine 150 mg/day. MAIN MEASUREMENTS CAMDEX interview. Psychiatric diagnosis followed the guidelines for "Major Depressive Episode" according to DSM-IV criteria. Severity of symptoms was evaluated using the "CGI" and "MADRS" scales. Cognitive state was assessed using the Mini-Mental State Examination. Side effects were assessed using the "Safetee-Up" schedule.

RESULTS:

Both groups had a significant decrease in depressive symptoms according to the MADRS scores after 6 weeks of treatment (P = 0.01). No significant differences between groups were detected regarding treatment outcome (t = 0.4; P = 0.7). Although the dropout rate was greater in the imipramine group, the overall tolerability among patients who completed the 6-week trial was similar in both test groups.

CONCLUSIONS:

Both sertraline and imipramine exhibited good efficacy and an acceptable side-effect profile for elderly depressed patients after 6 weeks of antidepressant treatment
Asunto(s)
Texto completo: 1 Colección: 01-internacional Base de datos: LILACS Asunto principal: Sertralina / Depresión / Atención Ambulatoria / Imipramina / Antidepresivos Tricíclicos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Qualitative_research Límite: Female / Humans / Male Idioma: En Revista: São Paulo med. j Asunto de la revista: Cirurgia Geral / Ciˆncia / Ginecologia / MEDICINA / Medicina Interna / Obstetr¡cia / Pediatria / Sa£de Mental / Sa£de P£blica Año: 2000 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Brasil
Texto completo: 1 Colección: 01-internacional Base de datos: LILACS Asunto principal: Sertralina / Depresión / Atención Ambulatoria / Imipramina / Antidepresivos Tricíclicos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Qualitative_research Límite: Female / Humans / Male Idioma: En Revista: São Paulo med. j Asunto de la revista: Cirurgia Geral / Ciˆncia / Ginecologia / MEDICINA / Medicina Interna / Obstetr¡cia / Pediatria / Sa£de Mental / Sa£de P£blica Año: 2000 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Brasil